Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DOOR
1176
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $14.2M | 0.01% |
269,300
+61,000
| +29% | +$3.16M |
|
1177
Clarus
CLAR
$141M
| $14.2M | 0.01% |
985,301
+29,028
| +3% | +$387K |
|
1178
Sarepta Therapeutics
SRPT
$1.94B
| $14.1M | 0.01% |
+92,878
| New | +$11.3M |
|
|
FLIC
1179
DELISTED
First of Long Island Corp
FLIC
| $14.1M | 0.01% |
701,681
+31,500
| +5% | +$696K |
|
1180
Embotelladora Andina Series B
AKO.B
$4.89B
| $14M | 0.01% |
653,300
+6,400
| +1% | +$135K |
|
1181
Community Trust Bancorp
CTBI
$1.42B
| $14M | 0.01% |
330,782
+9,200
| +3% | +$382K |
|
1182
Paylocity
PCTY
$7.73B
| $14M | 0.01% |
148,900
+95,100
| +177% | +$9.03M |
|
|
TRTX
1183
TPG RE Finance Trust
TRTX
$610M
| $14M | 0.01% |
723,400
+189,600
| +36% | +$3.72M |
|
1184
Nabors Industries
NBR
$1.33B
| $13.9M | 0.01% |
95,968
+95,400
| +16,796% | +$15.2M |
|
|
HOLX
1185
DELISTED
Hologic
HOLX
| $13.9M | 0.01% |
+289,318
| New | +$13.4M |
|
1186
US Bancorp
USB
$101B
| $13.9M | 0.01% |
265,100
-1,144,109
| -81% | -$59M |
|
1187
Cemex
CX
$16.2B
| $13.9M | 0.01% |
3,271,300
+1,526,100
| +87% | +$6.81M |
|
1188
Culp Inc
CULP
$43.8M
| $13.9M | 0.01% |
729,600
+8,100
| +1% | +$154K |
|
|
MNTV
1189
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $13.9M | 0.01% |
+839,600
| New | +$14.3M |
|
|
HCCI
1190
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $13.9M | 0.01% |
526,708
+22,508
| +4% | +$601K |
|
1191
Huntington Ingalls Industries
HII
$12.9B
| $13.8M | 0.01% |
61,600
-178,900
| -74% | -$38.3M |
|
1192
Companhia Siderúrgica Nacional
SID
$1.15B
| $13.8M | 0.01% |
3,203,700
-333,000
| -9% | -$1.34M |
|
1193
Vipshop
VIPS
$6.94B
| $13.8M | 0.01% |
+1,599,400
| New | +$12.9M |
|
|
RAVN
1194
DELISTED
Raven Industries Inc
RAVN
| $13.8M | 0.01% |
384,116
+102,716
| +37% | +$3.76M |
|
1195
First Citizens BancShares
FCNCA
$25.7B
| $13.8M | 0.01% |
30,600
+23,900
| +357% | +$10.5M |
|
1196
Lincoln Electric
LECO
$15.6B
| $13.8M | 0.01% |
167,138
-9,000
| -5% | -$748K |
|
|
EXK
1197
Endeavour Silver
EXK
$3.14B
| $13.7M | 0.01% |
6,685,225
+1,040,000
| +18% | +$2.12M |
|
1198
Takeda Pharmaceutical
TAK
$55.6B
| $13.7M | 0.01% |
+773,800
| New | +$14.1M |
|
1199
Harmony Gold Mining
HMY
$12.4B
| $13.7M | 0.01% |
6,029,521
+1,073,121
| +22% | +$1.98M |
|
1200
Reliance Steel & Aluminium
RS
$21.8B
| $13.7M | 0.01% |
+144,512
| New | +$12.9M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.